Header cover image

Spanish (IBEX) Biotech Industry Analysis

UpdatedFeb 24, 2024
DataAggregated Company Financials
Companies5
  • 7D7.1%
  • 3M-12.4%
  • 1Y-12.7%
  • YTD-22.4%

Over the last 7 days, the Biotech industry has risen 7.1%, driven by gains from Grifols of 8.4%. In contrast, the industry has lost 13% in the last 12 months. Earnings are forecast to grow by 36% annually.

Industry Valuation and Performance

Has the Spanish Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sat, 24 Feb 2024€7.7b€6.7b€31.4m187.6x244.9x1.1x
Mon, 22 Jan 2024€5.9b€6.7b€31.4m146x188.1x0.9x
Wed, 20 Dec 2023€9.5b€6.7b€31.5m236.9x301.8x1.4x
Fri, 17 Nov 2023€8.5b€6.7b€31.4m208.4x269.6x1.3x
Sun, 15 Oct 2023€7.8b€6.7b€23.8m487x327.4x1.2x
Tue, 12 Sep 2023€8.3b€6.7b€23.8m522.1x346.8x1.2x
Thu, 10 Aug 2023€8.6b€6.7b€23.8m538.9x362.5x1.3x
Sat, 08 Jul 2023€8.0b€6.6b€69.4m98.5x115.9x1.2x
Mon, 05 Jun 2023€7.7b€6.6b€69.3m94.5x111.5x1.2x
Wed, 03 May 2023€6.4b€6.3b€251.5m21.7x25.3x1x
Fri, 31 Mar 2023€6.5b€6.3b€250.4m23.1x26x1x
Sun, 26 Feb 2023€8.7b€5.4b€136.0m77.8x63.7x1.6x
Tue, 24 Jan 2023€8.6b€5.5b€137.1m76.2x62.6x1.6x
Thu, 22 Dec 2022€7.8b€5.5b€137.0m68x56.9x1.4x
Sat, 19 Nov 2022€7.3b€5.5b€137.0m62.4x53x1.3x
Mon, 17 Oct 2022€6.2b€5.5b€136.8m53.2x45.4x1.1x
Wed, 14 Sep 2022€8.7b€5.5b€136.8m77.4x63.4x1.6x
Fri, 12 Aug 2022€9.4b€5.5b€136.8m85.4x68.4x1.7x
Sun, 10 Jul 2022€11.3b€5.2b€266.2m38.2x42.3x2.2x
Tue, 07 Jun 2022€12.5b€5.2b€266.5m42.5x47.1x2.4x
Thu, 05 May 2022€11.2b€5.2b€268.5m37.8x41.6x2.2x
Sat, 02 Apr 2022€11.2b€5.2b€268.5m37.5x41.7x2.2x
Mon, 28 Feb 2022€10.5b€5.4b€720.9m15.7x14.6x1.9x
Wed, 26 Jan 2022€10.5b€5.4b€721.7m16.1x14.5x1.9x
Fri, 24 Dec 2021€10.5b€5.4b€721.8m16.5x14.6x2x
Sun, 21 Nov 2021€11.4b€5.4b€721.8m18x15.8x2.1x
Tue, 19 Oct 2021€13.2b€5.4b€729.0m20x18.1x2.4x
Thu, 16 Sep 2021€13.5b€5.4b€729.0m19.6x18.5x2.5x
Sat, 14 Aug 2021€13.3b€5.4b€729.0m18.4x18.3x2.5x
Wed, 09 Jun 2021€15.1b€5.5b€648.5m19.7x23.3x2.8x
Tue, 02 Mar 2021€14.5b€5.6b€750.7m17.3x19.3x2.6x
Price to Earnings Ratio

19.3x


Total Market Cap: €14.5bTotal Earnings: €750.7mTotal Revenue: €5.6bTotal Market Cap vs Earnings and Revenue0%0%0%
Spanish Biotech Industry Price to Earnings3Y Average 91.7x202220232024
Current Industry PE
  • Investors are optimistic on the Spanish Biotechs industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 245x which is higher than its 3-year average PE of 91.7x.
  • The 3-year average PS ratio of 1.8x is higher than the industry's current PS ratio of 1.1x.
Past Earnings Growth
  • The earnings for companies in the Biotechs industry have declined 65% per year over the last three years.
  • Meanwhile revenues for these companies have grown 6.1% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the Spanish Healthcare industry?

ES Market2.23%
Healthcare3.37%
Biotech7.08%
Biotech7.08%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
GRF Grifols€11.508.4%
+€604.0m
-8.8%PE333.5x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.